Startups with brilliant technologies and potential have gathered in Songdo International City, Incheon. This is the story of 'Incheon Startup Park,' a public-private cooperation project to create a startup ecosystem known as the 'Korean Silicon Valley.' The publicly-led 'POOM' program, overseen by the Incheon Free Economic Zone Authority and Incheon Technopark, operates in the InSta I space. In InSta II, the privately-led 'S² Bridge: Incheon' (Shinhan Square Bridge Incheon) platform, driven by Shinhan Financial Group (Chairman Yongbyung Jo) and Celltrion, supports the growth of startups. We met CEO Yongho Kim of 'RudaCure,' a publicly-nurtured company in InSta I, at Incheon Startup Park in Songdo.
RudaCure is a bio-healthcare specialist company developing new drug substances, a 'young venture' that launched in 2018. The company focuses on addressing 'unmet needs' in existing treatments.
One of the representative pipelines is the dry eye disease treatment.
RudaCure paid attention to dry eye disease, which has a high domestic prevalence. Currently,